{"id":3618,"date":"2018-01-05T09:48:35","date_gmt":"2018-01-05T14:48:35","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3618"},"modified":"2018-01-05T09:48:35","modified_gmt":"2018-01-05T14:48:35","slug":"ipo-pipeline-update-week-ending-1-5-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-week-ending-1-5-18\/","title":{"rendered":"IPO Pipeline Update (Week ending 1.5.18)"},"content":{"rendered":"


\n<\/a>IPO Boutique keeps apprised of the active pipeline. Currently there are 56 active IPOs in the pipeline as of January 5, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article.<\/strong><\/a><\/p>\n

\"Screen<\/a><\/p>\n

 <\/p>\n

NEW FILINGS<\/strong><\/p>\n

Company: PagSeguro Digital Ltd.
\nSymbol: PAGS
\nDescription: They are a disruptive provider of financial technology solutions focused primarily on Micro-Merchants, Small Companies and Medium-Sized Companies, or SMEs, in Brazil.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs & Co., Morgan Stanley, BofA Merrill Lynch, Credit Suisse, Deutsche Bank Securities, J.P. Morgan
\nFiled: 12-26-17
\nListed: Cash Raise: $100m<\/p>\n

Company: Gates Industrial Corporation plc
\nSymbol: GTES
\nDescription: They are a global manufacturer of innovative, highly engineered power transmission and fluid power solutions.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Citigroup, Morgan Stanley, UBS Investment Bank, Barclays, Credit Suisse, Goldman Sachs & Co., RBC Capital Markets
\nCo-Manager(s): Blackstone Capital Markets, Deutsche Bank Securities, Wells Fargo Securities, Current Capital Securities, KeyBanc Capital Markets, Siebert Cisneros Shank & Co., SunTrust Robinson Humphrey, Academy Securities, BTIG, Guggenheim Securities
\nFiled: 12-26-17
\nListed: Cash Raise: $100m<\/p>\n

Company: Menlo Therapeutics, Inc.
\nSymbol: MNLO
\nDescription: They are a late\u2011stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Piper Jaffray, Guggenheim Securities
\nCo-Manager(s): JMP Securities
\nFiled: 12-28-17
\nListed: Cash Raise: $97.5m<\/p>\n

Company: Solid Biosciences Inc.
\nSymbol: SLDB
\nDescription: Their mission is to cure Duchenne muscular dystrophy, or DMD, a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): J.P. Morgan, Goldman Sachs & Co., Leerink Partners
\nCo-Manager(s): Nomura, Chardan
\nFiled: 12-29-17
\nListed: Cash Raise: $100m<\/p>\n

Company: ARMO BioSciences, Inc.
\nSymbol: ARMO
\nDescription: They are a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary product candidates that activate the immune system of cancer patients to recognize and eradicate tumors.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Leerink, BMO
\nCo-Manager(s): Baird
\nFiled: 12-29-17
\nListed: Cash Raise: $86.25m<\/p>\n

Company: resTORbio, Inc.
\nSymbol: TORC
\nDescription: They are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Merrill Lynch, Leerink Partners, Evercore ISI, Wedbush PacGrow
\nFiled: 12-29-17
\nListed: Cash Raise: $85m<\/p>\n

Company: Central Puerto S.A.
\nSymbol: CEPU
\nDescription: They are the largest private sector power generation company in Argentina, as measured by generated power, according to data from CAMMESA. Their common shares are listed on the Bolsas y Mercados Argentinos S.A. under the symbol ‘CEPU’.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Merrill Lynch, J.P. Morgan, Morgan Stanley
\nFiled: 1-3-18
\nListed: Cash Raise: $100m<\/p>\n

TERMS ADDED<\/strong><\/p>\n

Company: Industrial Logistics Properties Trust
\nSymbol: ILPT
\nDescription: Industrial Logistics Properties Trust was recently formed to own and lease industrial and logistics properties throughout the United States.
\nShares: 20 million
\nPrice Range: $28.00-$31.00
\nTrade Date: 1\/12
\nUnderwriter(s): UBS Investment Bank, Citigroup, RBC Capital, Morgan Stanley, Wells Fargo Securities
\nCo-Manager(s): B. Riley FBR, BB&T Capital Markets, Janney Montgomery Scott, JMP Securities, Oppenheimer & Co.
\nTerms Added 1-2-18<\/p>\n

Company: Liberty Oilfield Services Inc.
\nSymbol: BDFC
\nDescription: They are a rapidly growing independent provider of hydraulic fracturing services to onshore oil and natural gas exploration and production (E&P) companies in North America.
\nShares: 10.7 million
\nPrice Range: $14.00-$16.00
\nTrade Date: 1\/12
\nUnderwriter(s): Morgan Stanley, Goldman Sachs & Co., Wells Fargo Securities, Citigroup, J.P. Morgan, Evercore ISI
\nCo-Manager(s): Simmons & Company, Tudor Pickering Holt & Co., Houlihan Lokey, Intrepid Partners, Petrie Partners Securities, SunTrust Robinson Humphrey
\nTerms Added 1-2-18<\/p>\n

Company: Entera Bio Ltd.
\nSymbol: ENTX
\nDescription: They are a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in orphan indications and other areas with significant unmet medical need.
\nShares: 5 million
\nPrice Range: $10.00-$12.00
\nTrade Date: TBD
\nUnderwriter(s): Oppenheimer & Co.
\nTerms Added: 1-5-17<\/p>\n

Company: ADT, Inc.
\nSymbol: ADT
\nDescription: They are the leading provider of monitored security, interactive home and business automation and related monitoring services in the United States and Canada.
\nShares: 111.1 million
\nPrice Range: $17.00-$19.00
\nTrade Date: 1\/19
\nUnderwriters: Morgan Stanley, Goldman Sachs & Co., Barclays, Deutsche Bank Securities, RBC Capital Markets, Citigroup, BofA Merrill Lynch, Credit Suisse
\nCo-Manager(s): Imperial Capital, Academy Securities, Allen & Company LLC, Apollo Global Securities, Citizens Capital Markets, LionTree, SunTrust Robinson Humphrey, The Williams Capital Group, L.P.
\nTerms Added: 1-5-17<\/p>\n","protected":false},"excerpt":{"rendered":"

IPO Boutique keeps apprised of the active pipeline. Currently there are 56 active IPOs in the pipeline as of January 5, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article.   NEW FILINGS Company:[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-3618","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3618","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3618"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3618\/revisions"}],"predecessor-version":[{"id":3620,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3618\/revisions\/3620"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3618"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3618"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}